Table 3.

Comparative IHC staining of anti-PTEN mAbs of FFPE samples from prostate and bladder urothelial carcinomas

mAb	Prostate (n = 81)		Bladder (n = 49)
	Negative/positive	% Negative	Negative/positive	% Negative
6H2.1	62/19	76.5	25/24	51
SP218	50/31	62	28/21	57
17.A (Ab-4)	41/40	49	29/20	59
Y184	33/48	41	12/37	24.5
138G6	45/36	56	27/22	55
D4.3	42/39	52	33/16	67

Data are as reported in Mingo et al. (2019).

FFPE, Formalin-fixed paraffin-embedded.